Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
177lu-psma-i&t (1 trial)
Hypersensitivity (Phase 2)
Prostatic Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (1 total)